Share This Page
Drug Price Trends for QC MUCUS RELIEF ER
✉ Email this page to a colleague
Average Pharmacy Cost for QC MUCUS RELIEF ER
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| QC MUCUS RELIEF ER 1,200 MG TB | 83324-0096-14 | 0.46044 | EACH | 2025-03-19 |
| QC MUCUS RELIEF ER 600 MG TAB | 83324-0097-20 | 0.33120 | EACH | 2025-03-19 |
| QC MUCUS RELIEF ER 600 MG TAB | 83324-0097-20 | 0.32454 | EACH | 2025-02-19 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for Guaifenesin-Based Drugs: A Focus on QC MUCUS RELIEF ER
Introduction to Guaifenesin
Guaifenesin, an ether of glycerin and guaiacol, is widely used as an expectorant to help clear mucus and phlegm from the airways, making breathing easier. It is a key ingredient in various cough and cold medications, including QC MUCUS RELIEF ER.
Global Guaifenesin Market Overview
The global guaifenesin market is projected to reach USD 95 million by 2027, growing at a Compound Annual Growth Rate (CAGR) of approximately 3.1% from 2022 to 2027[1].
Market Segmentation
By Application
The guaifenesin market is segmented into various applications, with the cough treatment drug segment being the fastest growing. This segment is expected to grow at a CAGR of around 3.7% during the forecast period. Guaifenesin is used in treating acute rhinosinusitis, cough, and mucus-related issues, often in combination with other medications like dextromethorphan and decongestants[1].
By End-Use Industry
The multispecialty hospital segment held the largest market share in 2021, with over 57% of the global guaifenesin market. Hospitals use guaifenesin extensively for treating cough, chest congestion, bronchitis, and other respiratory issues[1].
By Geography
The market is geographically segmented into North America, Europe, Asia-Pacific, South America, the Middle East, and Africa. The increasing cases of respiratory complications in these regions drive the demand for guaifenesin[1].
Expectorant Drugs Market Context
The broader expectorant drugs market, which includes guaifenesin-based products like QC MUCUS RELIEF ER, is valued at USD 17,648.2 million in 2024 and is projected to reach USD 38,455.4 million by 2034, growing at a CAGR of 4.3% from 2024 to 2034. This growth is driven by the increasing need for respiratory health management, especially post-pandemics like COVID-19[3].
Price Projections and Market Dynamics
Demand Drivers
- The growing application of guaifenesin in cough treatment drugs, particularly in hospitals and clinics, is a significant driver. The Indian pharmaceutical sector, for example, is expected to reach USD 65 billion by 2024 and around USD 120-130 billion by 2030, which will further boost the demand for guaifenesin[1].
- Increasing consumer interest in oral medications, including expectorants, contributes to the demand. China, with its reliance on traditional Chinese medicine and high incidence of respiratory diseases, is a key market[3].
Price Trends
The price of guaifenesin-based drugs like QC MUCUS RELIEF ER can be influenced by several factors:
- Raw Material Costs: Fluctuations in the cost of glycerin and guaiacol can impact the final product price.
- Regulatory Environment: Changes in regulatory standards, such as those related to pharmaceutical manufacturing and safety, can affect production costs and subsequently prices.
- Market Competition: The presence of substitutes and the overall competitive landscape in the expectorant drugs market can influence pricing strategies.
Challenges and Opportunities
- Availability of Substitutes: The global guaifenesin market faces challenges from the availability of substitute expectorants, which can impact market share and pricing.
- Technological Advancements: Innovations in drug delivery and processing can enhance the efficacy and appeal of guaifenesin-based products, potentially leading to higher demand and stable or increasing prices[1].
Regional Market Analysis
North America
The North American market, particularly the U.S., sees significant demand for guaifenesin due to high hospital drug expenses. According to the American Hospital Association, hospital drug expenses per adjusted discharge increased by 30.3% in 2020-21 compared to 2019[1].
Asia-Pacific
China is a key market with an anticipated CAGR of 8.1% for expectorant drugs by 2034. The country's healthcare system, which includes traditional Chinese medicine, drives the demand for expectorant herbs and medications[3].
Key Takeaways
- The cough treatment drug segment is the fastest-growing segment in the guaifenesin market.
- Multispecialty hospitals are the largest end-users of guaifenesin.
- The global expectorant drugs market, including guaifenesin-based products, is expected to grow significantly due to increasing respiratory health concerns.
- Regional markets, especially in Asia-Pacific, are driving growth due to traditional medicine practices and high incidence of respiratory diseases.
FAQs
1. What is the projected market size of the global guaifenesin market by 2027? The global guaifenesin market is forecasted to reach USD 95 million by 2027[1].
2. Which segment is the fastest-growing in the guaifenesin market? The cough treatment drug segment is the fastest-growing, expected to grow at a CAGR of around 3.7% during the forecast period[1].
3. What is the significance of the multispecialty hospital segment in the guaifenesin market? The multispecialty hospital segment held the largest market share in 2021, with over 57% of the global guaifenesin market[1].
4. How does the broader expectorant drugs market impact guaifenesin-based products? The expectorant drugs market, valued at USD 17,648.2 million in 2024, is projected to reach USD 38,455.4 million by 2034, driving demand for guaifenesin-based products like QC MUCUS RELIEF ER[3].
5. What are the key drivers of the guaifenesin market? Key drivers include growing applications in cough treatment drugs, increasing consumer interest in oral medications, and advancements in hospital infrastructure and technology[1][3].
Cited Sources
- IndustryARC: Guaifenesin Market Size Report, 2022-2027.
- Federal Register: Rules and Regulations, May 7, 2024.
- Future Market Insights: Global Expectorant Drugs Market Growth Projection 2024-2034.
More… ↓
